Genomic sequencing in India: Where are we and what’s next | Dr. Sudha Rao

Rare diseases, prenatal testing, and the future of genetic screening I Dr. Ashwin Dalal

Genetic testing has the power to transform healthcare, but in India, accessibility remains a challenge. In this episode, Dr. Ashwin Dalal, a pioneer in medical genetics, unpacks what’s driving progress and what’s holding us back. From decoding rare diseases to shaping national genomic initiatives, he shares firsthand insights on the breakthroughs, policy shifts, and innovations that could make genetic diagnostics a standard part of medical care.

How does microbiome sequencing unlock precision medicine? I Mr. Kumar Sankaran

The microbiome data holds a vault that could reshape the future of medicine. In this episode, we sit down with Mr. Kumar Shakaran, CEO of Leucine Rich Bio, to talk about how gut microbiome sequencing is changing the game—making disease prediction and personalized treatments a real possibility. We get into the challenges, the breakthroughs, and what’s next for microbiome-driven medicine. Tune in now.

Smart algorithms, pooled testing, & the future of molecular diagnostics I Dr. Manoj Gopalkrishnan

In this episode, we’re joined by Dr. Manoj Gopalkrishnan, the founder of Algorithmic Biologics, to explore the future of molecular computing and diagnostics. He shares how his work is optimizing pooling strategies, transforming diagnostics, and streamlining molecular testing workflows. Tune in for a deep dive into the tech shaping the next era of genomics!

Genomic sequencing in India: Where are we and what’s next | Dr. Sudha Rao

Welcome to the very first episode of our podcast series, Beyond the Bench! We recommend subscribing now, as you won't want to miss out on this content. We chat with Dr. Sudha Rao, an entrepreneur and researcher who’s been shaping the genomics landscape in India for over two decades. As the co-founder of Genotypic Technology and the founder of Dhiti Omics Technology Pvt Ltd, Dr. Sudha has been instrumental in bringing genomic services to India, setting up world-class facilities in molecular biology, microarray, and next-gen sequencing. But what does it really take to build something like this from the ground up? We dig into the journey of starting one of India’s first genomic service labs and the many hurdles they had to overcome. We talk about how genomics went from a niche field to an essential part of the healthcare system in India and what it took to make that happen - think technology breakthroughs, collaborations, and some serious perseverance. We also talk about where genomics is headed. Dr. Sudha shares her vision for the future and a bold prediction for the next decade that could change everything. It’s a conversation full of insights and big ideas. Grab a coffee and join us for a peek into the future of healthcare in India and beyond. About Cambrian Bioworks: We’re a biotech firm headquartered in Bangalore, India. We build automation tools for molecular and genomic workflows. We’re a team of scientists, engineers, and chemists working to make genomics accessible and affordable to the masses. Visit our website to know more: https://cambrianbioworks.com/